Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery
Lipoprotein insulin resistance (LPIR) is a composite biomarker representative of atherogenic dyslipidemia characteristic of early insulin resistance. It is elevated in obesity and may provide information not captured in glycosylated hemoglobin and homeostatic model assessment for insulin resistance. While bariatric surgery reduces diabetes incidence and resolves metabolic syndrome, the effect of bariatric surgery on LPIR is untested.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Ruina Zhang, BingXue Lin, Manish Parikh, Edward A. Fisher, Jeffrey S. Berger, Jose O. Aleman, Sean P. Heffron Tags: Original article Source Type: research
More News: Bariatric Surgery | Diabetes | Eating Disorders & Weight Management | Endocrinology | Insulin | Metabolic Syndrome | Obesity | Surgery